BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28536823)

  • 1. Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.
    Gentileschi S; Rigante D; Vitale A; Sota J; Frediani B; Galeazzi M; Cantarini L
    Clin Rheumatol; 2017 Jul; 36(7):1687-1690. PubMed ID: 28536823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-demand treatment with anakinra: a treatment option for selected TRAPS patients.
    Grimwood C; Despert V; Jeru I; Hentgen V
    Rheumatology (Oxford); 2015 Sep; 54(9):1749-51. PubMed ID: 26078218
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
    Delaleu J; Deshayes S; Rodrigues F; Savey L; Rivière E; Silva NM; Aouba A; Amselem S; Rabant M; Grateau G; Giurgea I; Georgin-Lavialle S
    Rheumatology (Oxford); 2021 Dec; 60(12):5775-5784. PubMed ID: 33715002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
    La Torre F; Muratore M; Vitale A; Moramarco F; Quarta L; Cantarini L
    Rheumatol Int; 2015 Nov; 35(11):1943-7. PubMed ID: 26048626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra.
    Cattalini M; Meini A; Monari P; Gualdi G; Arisi M; Pelucchi F; Bolognini S; Gattorno M; Calzavara-Pinton PG; Plebani A
    Dermatol Online J; 2013 Nov; 19(11):20405. PubMed ID: 24314780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.
    Cantarini L; Lucherini OM; Muscari I; Frediani B; Galeazzi M; Brizi MG; Simonini G; Cimaz R
    Autoimmun Rev; 2012 Nov; 12(1):38-43. PubMed ID: 22884554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Setting up TRAPS.
    Pettersson T; Kantonen J; Matikainen S; Repo H
    Ann Med; 2012 Mar; 44(2):109-18. PubMed ID: 21284532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis.
    Obici L; Meini A; Cattalini M; Chicca S; Galliani M; Donadei S; Plebani A; Merlini G
    Ann Rheum Dis; 2011 Aug; 70(8):1511-2. PubMed ID: 21173015
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.
    Vinit C; Georgin-Lavialle S; Theodoropoulou A; Barbier C; Belot A; Mejbri M; Pillet P; Pachlopnik J; Poignant S; Rebelle C; Woerner A; Koné-Paut I; Hentgen V
    Front Immunol; 2021; 12():744780. PubMed ID: 34858402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
    Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
    Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].
    Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V
    Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal recessive transmission of TRAPS in a family with a novel TNFRSF1A mutation.
    Wong KK; Jackson J; Whidborne R; Mallon D; Bennetts B; D'Orsogna LJ
    Scand J Rheumatol; 2015 May; 44(3):255-6. PubMed ID: 25744939
    [No Abstract]   [Full Text] [Related]  

  • 13. Sarcoid-like granulomatosis in a patient treated by interleukin-1 receptor antagonist for TNF-receptor-associated periodic syndrome.
    Sacre K; Pasqualoni E; Descamps V; Choudat L; Debray MP; Papo T
    Rheumatology (Oxford); 2013 Jul; 52(7):1338-40. PubMed ID: 23302761
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.
    Sinožić D; Toplak N; Milotić I
    J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent fever and arthralgia as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Chinese girl: a case report and review of the literature.
    Chen Y; Huang X; Zheng S; Zhu Z; Yang W; Liu J
    Clin Rheumatol; 2018 May; 37(5):1433-1438. PubMed ID: 29450850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant.
    Camprubí D; Mitjavila F; Arostegui JI; Corbella X
    Int J Rheum Dis; 2017 Apr; 20(4):510-514. PubMed ID: 27990755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome.
    Gattorno M; Pelagatti MA; Meini A; Obici L; Barcellona R; Federici S; Buoncompagni A; Plebani A; Merlini G; Martini A
    Arthritis Rheum; 2008 May; 58(5):1516-20. PubMed ID: 18438813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
    Lucherini OM; Obici L; Ferracin M; Fulci V; McDermott MF; Merlini G; Muscari I; Magnotti F; Dickie LJ; Galeazzi M; Negrini M; Baldari CT; Cimaz R; Cantarini L
    PLoS One; 2013; 8(9):e73443. PubMed ID: 24066048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
    Kirresh A; Everitt A; Kon OM; DasGupta R; Pickering MC; Lachmann HJ
    Pract Neurol; 2016 Aug; 16(4):304-7. PubMed ID: 26965498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.